Akira, S., Uematsu, S., and Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801, 2006.

Arch, R.H., Gedrich, R.W., and Thompson, C.B. Tumor necrosis factor receptor-associated factors (TRAFs)—a family of adapter proteins that regulates life and death. Genes & development 12, 2821-2830, 1998.

Bradley, J.R., and Pober, J.S. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20, 6482-6491, 2001.

Cao, Z., Henzel, W.J., and Gao, X. IRAK: A Kinase Associated with the Interleukin-1 Receptor. Science 271, 1128-1131, 1996a.

Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., and Goeddel, D.V. TRAF6 is a signal transducer for interleukin-1. Nature 383, 443-446, 1996b.

Croston, G.E., Cao, Z., and Goeddel, D.V. NF-κB activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. Journal of Biological Chemistry 270, 16514-16517, 1995.

Das, A., Middleton, A.J., Padala, P., Ledgerwood, E.C., Mace, P.D., and Day, C.L. The structure and ubiquitin binding properties of TRAF RING heterodimers. Journal of Molecular Biology 433, 166844, 2021.

Flannery, S., and Bowie, A.G. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. Biochemical pharmacology 80, 1981-1991, 2010.

Ha, H., Han, D., and Choi, Y. TRAF‐mediated TNFR‐family signaling. Current protocols in immunology 87, 11.19 D. 11-11.19 D. 19, 2009.

Huang, W.-C., Liao, J.-H., Hsiao, T.-C., Wei, T.-Y.W., Maestre-Reyna, M., Bessho, Y., and Tsai, M.-D. Binding and enhanced binding between key immunity proteins TRAF6 and TIFA. ChemBioChem 20, 140-146, 2019a.

Huang, W.C., Liao, J.H., Hsiao, T.C., Wei, T.Y.W., Maestre‐Reyna, M., Bessho, Y., and Tsai, M.D. Binding and enhanced binding between key immunity proteins TRAF6 and TIFA. ChemBioChem 20, 140-146, 2019b.

Ishida, T., Mizushima, S.-i., Azuma, S., Kobayashi, N., Tojo, T., Suzuki, K., Aizawa, S., Watanabe, T., Mosialos, G., and Kieff, E. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. Journal of Biological Chemistry 271, 28745-28748, 1996.

Janssens, S., and Beyaert, R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Molecular cell 11, 293-302, 2003.

Ji, L., Fan, X., Hou, X., Fu, D., Bao, J., Zhuang, A., Chen, S., Fan, Y., and Li, R. Jieduquyuziyin prescription suppresses inflammatory activity of MRL/lpr mice and their bone marrow-derived macrophages via inhibiting expression of IRAK1-NF-κb signaling pathway. Frontiers in Pharmacology 11, 1049, 2020.

Kobayashi, K., Hernandez, L.D., Galán, J.E., Janeway Jr, C.A., Medzhitov, R., and Flavell, R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202, 2002.

Kollewe, C., Mackensen, A.-C., Neumann, D., Knop, J., Cao, P., Li, S., Wesche, H., and Martin, M.U. Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling. Journal of Biological Chemistry 279, 5227-5236, 2004.

Krissinel, E., and Henrick, K. Inference of macromolecular assemblies from crystalline state. Journal of Molecular Biology 372, 774-797, 2007.

Lamothe, B., Campos, A.D., Webster, W.K., Gopinathan, A., Hur, L., and Darnay, B.G. The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. Journal of Biological Chemistry 283, 24871-24880, 2008.

LI, M., and ZHOU, L.-j. Research progress on the relationship between TRAF6 and tumor. Biotechnology Bulletin 33, 24, 2017.

Li, S., Strelow, A., Fontana, E.J., and Wesche, H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proceedings of the National Academy of Sciences 99, 5567-5572, 2002.

Lin, S.-C., Lo, Y.-C., and Wu, H. Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling. Nature 465, 885-890, 2010.

Manalastas-Cantos, K., Konarev, P.V., Hajizadeh, N.R., Kikhney, A.G., Petoukhov, M.V., Molodenskiy, D.S., Panjkovich, A., Mertens, H.D., Gruzinov, A., and Borges, C. ATSAS 3.0: expanded functionality and new tools for small-angle scattering data analysis. Journal of applied crystallography 54, 343-355, 2021.

Medzhitov, R. Toll-like receptors and innate immunity. Nature Reviews Immunology 1, 135-145, 2001.

Mercier, P., Lewis, M.J., Hau, D.D., Saltibus, L.F., Xiao, W., and Spyracopoulos, L. Structure, interactions, and dynamics of the RING domain from human TRAF6. Protein science 16, 602-614, 2007.

Middleton, A.J., Budhidarmo, R., Das, A., Zhu, J., Foglizzo, M., Mace, P.D., and Day, C.L. The activity of TRAF RING homo-and heterodimers is regulated by zinc finger 1. Nature communications 8, 1-10, 2017a.

Middleton, A.J., Budhidarmo, R., Das, A., Zhu, J., Foglizzo, M., Mace, P.D., and Day, C.L. The activity of TRAF RING homo-and heterodimers is regulated by zinc finger 1. Nature communications 8, 1788, 2017b.

Muzio, M., Ni, J., Feng, P., and Dixit, V.M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612-1615, 1997.

Park, Y.C., Burkitt, V., Villa, A.R., Tong, L., and Wu, H. Structural basis for self-association and receptor recognition of human TRAF2. Nature 398, 533-538, 1999.

Rong, Y., Wang, D., Wu, W., Jin, D., Kuang, T., Ni, X., Zhang, L., and Lou, W. TRAF6 is over-expressed in pancreatic cancer and promotes the tumorigenicity of pancreatic cancer cells. Medical Oncology 31, 1-10, 2014.

Rothe, M., Wong, S.C., Henzel, W.J., and Goeddel, D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692, 1994.

Sameer, A.S., and Nissar, S. Toll-like receptors (TLRs): structure, functions, signaling, and role of their polymorphisms in colorectal cancer susceptibility. BioMed Research International 2021, 2021.

Schrodinger, L. The PyMOL molecular graphics system. Version 1, 8, 2015.

Shi, Z., Zhang, Z., Zhang, Z., Wang, Y., Li, C., Wang, X., He, F., Sun, L., Jiao, S., and Shi, W. Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling. Journal of Biological Chemistry 290, 26811-26820, 2015.

Sun, H., Li, X., Fan, L., Wu, G., Li, M., and Fang, J. TRAF6 is upregulated in colon cancer and promotes proliferation of colon cancer cells. The international journal of biochemistry & cell biology 53, 195-201, 2014.

Suzuki, N., Suzuki, S., Duncan, G.S., Millar, D.G., Wada, T., Mirtsos, C., Takada, H., Wakeham, A., Itie, A., and Li, S. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416, 750-754, 2002.

Svergun, D.I. Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophysical journal 76, 2879-2886, 1999.

Takeuchi, M., Rothe, M., and Goeddel, D.V. Anatomy of TRAF2: distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. Journal of Biological Chemistry 271, 19935-19942, 1996.

Thomas, J.A., Allen, J.L., Tsen, M., Dubnicoff, T., Danao, J., Liao, X.C., Cao, Z., and Wasserman, S.A. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. The Journal of Immunology 163, 978-984, 1999.

Wajant, H., Henkler, F., and Scheurich, P. The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cellular signalling 13, 389-400, 2001.

Wang, L., Qiao, Q., Ferrao, R., Shen, C., Hatcher, J.M., Buhrlage, S.J., Gray, N.S., and Wu, H. Crystal structure of human IRAK1. Proceedings of the National Academy of Sciences 114, 13507-13512, 2017.

Wesche, H., Gao, X., Li, X., Kirschning, C.J., Stark, G.R., and Cao, Z. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. Journal of Biological Chemistry 274, 19403-19410, 1999.

Xie, P. TRAF molecules in cell signaling and in human diseases. Journal of molecular signaling 8, 1-31, 2013.

Xu, L.-G., Li, L.-Y., and Shu, H.-B. TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. Journal of Biological Chemistry 279, 17278-17282, 2004.

Yao, F., Han, Q., Zhong, C., and Zhao, H. TRAF6 promoted the tumorigenicity of esophageal squamous cell carcinoma. Tumor Biology 34, 3201-3207, 2013.

Ye, H., Arron, J.R., Lamothe, B., Cirilli, M., Kobayashi, T., Shevde, N.K., Segal, D., Dzivenu, O.K., Vologodskaia, M., and Yim, M. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443-447, 2002.

Yin, Q., Lin, S.-C., Lamothe, B., Lu, M., Lo, Y.-C., Hura, G., Zheng, L., Rich, R.L., Campos, A.D., and Myszka, D.G. E2 interaction and dimerization in the crystal structure of TRAF6. Nature structural & molecular biology 16, 658-666, 2009.

Zhang, X.-L., Dang, Y.-W., Li, P., Rong, M.-H., Hou, X.-X., Luo, D.-Z., and Chen, G. Expression of tumor necrosis factor receptor-associated factor 6 in lung cancer tissues. Asian Pacific Journal of Cancer Prevention 15, 10591-10596, 2015.

Zhou, Z., Tian, Z., Zhang, M., Zhang, Y., Ni, B., and Hao, F. Upregulated IL-1 receptor-associated kinase 1 (IRAK1) in systemic lupus erythematosus: IRAK1 inhibition represses Th17 differentiation with therapeutic potential. Immunological Investigations 47, 468-483, 2018.